Replies to post #93844 on $heff's $tation of $tocks & $olid DD

[ash111]

KTOV ($20m cap,passed Phase 3) having another Solid day,6's here.https://www.accesswire.com/viewarticle.aspx?id=439525

a pocket change money for Pfizer to acquire.imo.Folks might drop Celebrex overnight and not worry about side effects and switch to KIT-302 (kitov's "improved Celebrex").imo

if kitov take only 10% of their market share alone(Pfizer had $1.7B in sales 2014-15 in average),on 70% profit margin,will brings her to almost $200m net income per year. 10 times market cap($20m current cap) might be equal to only one year net income. calculate PV and you ended up with a present value of $1B+. a major pharma can plop down $200m- $300m on a buyout for a billion dollar risk reward as well even before the drug hit the market (2017),imo.